Emerging role and therapeutic potential of lncrnas in colorectal cancer

Laura Schwarzmueller, Oscar Bril, Louis Vermeulen, Nicolas Léveillé

Research output: Contribution to journalReview articleAcademicpeer-review

28 Citations (Scopus)

Abstract

Maintenance of the intestinal epithelium is dependent on the control of stem cell (SC) proliferation and differentiation. The fine regulation of these cellular processes requires a complex dynamic interplay between several signaling pathways, including Wnt, Notch, Hippo, EGF, Ephrin, and BMP/TGF-β. During the initiation and progression of colorectal cancer (CRC), key events, such as oncogenic mutations, influence these signaling pathways, and tilt the homeostatic balance towards proliferation and dedifferentiation. Therapeutic strategies to specifically target these deregulated signaling pathways are of particular interest. However, systemic blocking or activation of these pathways poses major risks for normal stem cell function and tissue homeostasis. Interestingly, long non-coding RNAs (lncRNAs) have recently emerged as potent regulators of key cellular processes often deregulated in cancer. Because of their exceptional tissue and tumor specificity, these regulatory RNAs represent attractive targets for cancer therapy. Here, we discuss how lncRNAs participate in the maintenance of intestinal homeostasis and how they can contribute to the deregulation of each signaling pathway in CRC. Finally, we describe currently available molecular tools to develop lncRNA-targeted cancer therapies.
Original languageEnglish
Article number3843
Pages (from-to)1-21
Number of pages21
JournalCancers
Volume12
Issue number12
DOIs
Publication statusPublished - 1 Dec 2020

Keywords

  • Colorectal cancer
  • LncRNAs
  • RNA-based therapeutics

Cite this